Today: September 24, 2024
January 24, 2023
1 min read

Diabetes drug in short supply in US; many Dominicans use it

Diabetes drug in short supply in US;  many Dominicans use it

NY.- In recent months, the drug Ozempic, which many Dominicans use under prescription to combat diabetes, has been in short supply in the United States, colliding with global supply problems, reports the Anglo-Saxon press.

It is a medication given once a week to improve blood sugar, along with diet and exercise, reduces the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease.

Ozempic’s popularity is not due to rising rates of diabetes, but to its weight-loss benefits, doctors say.

Without medication, people with type 2 diabetes are at risk of high blood sugar that can lead to heart disease, kidney disease, hearing loss, and stroke.

Ozempic works by mimicking a hormone in the body that regulates insulin levels. Allison Schneider, a spokeswoman for the company that made the factory, admitted that the company is still experiencing supply problems.

With the interest that Dominicans who consume this drug know the side effects, we visit the Ozempic page: Ozempic® (semaglutide) Injection 0.5 mg or 1 mg for Type 2 Diabetes which displays the following data.

Possible Side Effects: Nausea, vomiting, diarrhea, stomach (abdominal) pain, constipation, and change in vision.

Your risk of low blood sugar may be higher if you use it with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.

Source link

Latest Posts

They celebrated "Buenos Aires Coffee Day" with a tour of historic bars - Télam
Cum at clita latine. Tation nominavi quo id. An est possit adipiscing, error tation qualisque vel te.

Categories

Mass: "Uruguay is the younger brother of Mercosur"
Previous Story

Mass: "Uruguay is the younger brother of Mercosur"

Loan placement will grow 27% due to school campaign
Next Story

Loan placement will grow 27% due to school campaign

Latest from Blog

Go toTop